This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Harada M, Akashi K, Hayashi S et al. Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission Int J Hematol 1997 66: 297–301
Taufri A, Andreeff M . Kinetic rationale for cytokine induced recruitment of myeloblastic leukemia followed by cycle specific chemotherapy in vitro Leukemia 1990 4: 826–834
Tjan-Heijnen VC, Biesma B, Festen J et al. Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma J Clin Oncol 1998 16: 2708–2714
Pecora AL . Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients Bone Marrow Transplant 1999 23: (Suppl. 2) 7–12
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, B., Kook, H., Hwang, T. et al. Autologous peripheral blood stem cell transplantation using G-CSF combined conditioning in AML patients: delayed platelet recovery and frequent early relapse. Bone Marrow Transplant 26, 459–460 (2000). https://doi.org/10.1038/sj.bmt.1702513
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702513
This article is cited by
-
High-dose chemotherapy with autologous PDSCT as post-remission therapy for AML
Bone Marrow Transplantation (2001)